Novel coronavirus mitigation measures implemented by radiotherapy centres in low and middle-income countries: a systematic review by Donkor, Andrew et al.
303https://journals.viamedica.pl/rpor
review article
reports of Practical Oncology and radiotherapy 




Address for correspondence: Andrew Donkor, Faculty of Health, University of Technology Sydney, IMPACCT (Improving Palliative, 
Aged and Chronic Care through Clinical Research and Translation), NSW Australia; Korle-Bu Teaching Hospital,  
National Centre for Radiotherapy and Nuclear Medicine, Accra, Ghana; e-mail: Andrew.Donkor@uts.edu.au
Novel coronavirus mitigation measures implemented 
by radiotherapy centres in low and middle-income countries: 
a systematic review
Andrew Donkor1, 2, Vivian Della Atuwo-Ampoh3, Craig Opie4, Frederick Yakanu2, Dorothy Lombe5, 
Jamal Khader6
1Faculty of Health, University of Technology Sydney, IMPACCT 
(Improving Palliative, Aged and Chronic Care through Clinical Research and Translation), NSW Australia 
2Korle-Bu Teaching Hospital, National Centre for Radiotherapy and Nuclear Medicine, Accra, Ghana
3Department of Medical Imaging, School of Allied Health Sciences, University of Health and Allied Sciences, Ghana
4Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia
5Cancer Diseases Hospital, Zambia
6King Hussein Cancer Center, Amman, Jordan
AbstrAct
background: the aim of the study was to identify strategies adopted by radiotherapy centres in low- and middle-income 
countries (lMics) to mitigate the effects of cOviD-19. Studies summarising cOviD-19 mitigation strategies designed and 
implemented by radiotherapy centres in lMics to avoid delays, deferrments and interruptions of radiotherapy services are 
lacking.
Materials and methods: a systematic review was conducted and reported in accordance with the preferred reporting items 
for systematic review and meta-analysis guideline. Ovid embase, Ovid MeDliNe and ciNaHl were searched for peer-reviewed 
articles that reported measures adopted by radiotherapy centres in lMics to reduce the risk of cOviD-19. information on dif-
ferent strategies were extracted from the included studies and textual narrative synthesis was conducted.
results: Of 60 articles retrieved, eleven were included. Majority of the studies were conducted in china. ten of the included 
studies employed a qualitative design. Four themes were identified: preparing and equipping staff; reinforcing infection pre-
vention and control policies; strengthening coordination and communication; and maintaining physical distancing. Studies 
reported that radiotherapy centres had: formed cOviD-19 response multidisciplinary team; maximised the use of telehealth; 
adjusted the layout of waiting areas; divided staff into teams; dedicated a room for isolating suspected cases; and adopted 
triage systems.
conclusions: local adaptation of established global strategies coupled with timely development of guidelines, flexibility and 
innovation have allowed radiotherapy leaders to continue to deliver radiotherapy services to cancer patients in lMics during 
the cOviD-19 crisis. robust data collection must be encouraged in lMics to provide an evidence-based knowledge for use in 
the event of another pandemic.
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introduction
The challenges posed by novel coronavirus 
(COVID-19) are unprecedented, and policy and 
decision-makers around the globe are dealing with 
several complexities and uncertainties. No vaccine 
is currently available. As predicted by mathemati-
cal models, the number of severe acute respira-
tory syndrome coronavirus 2 (SARS-CoV-2) in-
fections increased in the winter season of low- and 
middle-income countries (LMICs) in the southern 
hemisphere, which is a major concern because 
of the fragile health systems [1, 2]. Governments 
have demonstrated strong commitments by adopt-
ing measures, such as stay-at-home recommenda-
tions, business closures and travel restrictions to 
contain the spread of the virus [3] Some studies 
have demonstrated that people with cancer are at 
greater risk from COVID-19 because they often 
have multiple comorbidities, tend to be older and 
immunosuppressed due to the disease or its treat-
ment [4]. In some countries, patients were ad-
vised not to visit hospitals because of COVID-19 
infection risk [5]. However, this is not a realistic 
long-term solution for radiotherapy centres and 
people living with cancer.
Radiotherapy is a critical component of univer-
sal health coverage and it is crucial for policy and 
decision-makers to prioritise this essential service 
to avoid disruptive effects from COVID-19. Most 
radiotherapy centres in LMICs already face re-
source issues including understaffing and budget 
constraints. The problems faced in these countries 
are compounded by misinformation, sociocultural 
and religious issues, as well as poor sanitary con-
ditions. The delivery of safe and effective radio-
therapy services in LMICs in a time of COVID-19 
pandemic relies on appropriate policy, healthcare 
organisation, community and patient-level inter-
ventions. An analysis of an online Twitter discus-
sion by members of the global radiation oncology 
community highlighted the importance of creat-
ing and implementing a programme that prepares, 
communicates, operates and compensates when 
radiotherapy is paused during the COVID-19 pan-
demic [6].
Radiotherapy leaders in high-income coutries 
(HICs) have generally pursued cautious policies 
to help staff, cancer patients and their families stay 
safe at radiotherapy centres during the COVID-19 
pandemic [7]. Some have adopted: physical dis-
tancing by reorganising spaces and reducing the 
number of acompanying family members; triage 
systems; hand hygiene; use of personal protective 
equipment (PPE) for all cancer patients regardless 
of known COVID-19 status; and use of telehealth 
for training, multidisiciplinary team meetings and 
follow-ups [7, 8]. Similar strategies are now increas-
ingly being implemented in most LMICs often with 
limited support, weak infrastructure and less robust 
local evidence. As a result, the prospect for sustain-
ing and providing equitable radiotherapy service is 
questionable [9].
To avoid unsustainable service delivery, it is criti-
cal that radiotherapy leaders in LMICs formulate 
and implement COVID-19 policy responses, which 
align with local priorities, needs and resources. At 
present, no studies have been conducted to identify 
and understand lessons learned based on LMICs 
radiotherapy centres’ experiences in responding to 
the COVID-19 pandemic. Therefore, the aim of 
this study is to identify strategies adopted by radio-
therapy centres in LMICs to mitigate the effects of 
COVID-19.
Materials and methods
This systematic review is reported in accordance 
with the preferred reporting items for systematic 
review and meta-analysis (PRISMA) guideline [10].
eligibility criteria
Included studies satisfied three criteria, which 
were: i) studies had to focus on COVID-19 and 
radiotherapy services in any country classified as 
LMIC as defined by the World Bank Group; ii) 
studies have to describe measures adopted to re-
duce the risk of COVID-19 in a radiotherapy centre; 
and iii) primary studies published in peer-reviewed 
journals of any design and in English language. 
Editorials, opinion pieces, comments, letters, stud-
ies focused on high-income settings and studies in 
languages other than English were excluded.  
information sources
Three electronic databases were searched, name-
ly: Ovid Embase, Ovid MEDLINE(R) and In-Pro-
cess & Other Non-Indexed Citations and CINAHL. 
A manual search of the reference lists of included 
studies was performed.
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Search strategy
The search strategy included terms relating to 
four concepts: i) cancer; ii) radiotherapy; iii) CO-
VID-19; and iv) LMICs. Subject headings, indexed 
keywords and free text terms relating to the four 
concepts appearing in titles and/or abstracts were 
combined using “AND” or “OR” (see Appendix 1 
in Supplementary File). The initial search strategy 
was developed in Ovid MEDLINE and adapted for 
other databases. Databases were searched on 1 July 
2020 and updated on 3 August 2020.
Study selection
Two authors screened titles and abstracts of all 
citations retrieved for inclusion. Conflicts were re-
solved through discussion. Studies were excluded if 
they clearly did not meet the inclusion criteria. Full 
texts of studies not excluded during the title and 
abstract screening were obtained.
Data extraction
An electronic data extraction form was devel-
oped, and two reviewers independently abstracted 
the contents of each included study. The data ex-
tracted included: study characteristics; character-
istics of strategies implemented; reasons for adopt-
ing the strategy; and implementation challenges. 
Abstracted data were then discussed through an 
online platform. The risk of bias for each study was 
appraised using Joanna Briggs Institute Critical Ap-
praisal Checklist for Qualitative Research indepen-
dently by two reviewers and disagreements were 
resolved via discussion [11].
Data synthesis
Textual narrative synthesis was conducted. Includ-
ed studies were independently coded by two reviews 
without a framework. Through thematic analysis, 
studies were arranged into homogeneous groups, 
and similarities and differences were compared 
across studies [12]. Each study was read and reread to 
achieve immersion, identify ideas and/or concepts of 
interest and completed with data reduction and com-
parison. Emerging themes were explored, refined and 
any discrepancies were resolved through discussion.
results
Of the 60 articles retrieved, seven articles were 
removed due to duplication. The remaining 53 ar-
ticles were screened, and 11 articles were excluded 
based on their title and abstract. Next, 42 articles 
underwent full-text review and 31 were excluded 
because they did not satisfy the inclusion criteria, 
leaving 11 articles for data extraction (see Fig. 1). 
The level of evidence for all of the included studies 
was low.
characteristics of included studies
Characteristics of the included studies are dis-
played in Table 1. The majority of the studies were 
conducted in China [13–16]. Other studies were 
conducted in Iran [17–19], Brazil [20] and Zambia 
[21]. Ten of the included studies employed a quali-
tative design [13–16, 18–22]. A variety of methods 
were used including case reports [13, 14, 16, 19, 
21], experts consensus [17, 18, 20, 22], cross-sec-
tional survey [23] and critical review [15]. There 
is a strong support for hypofractionated radiother-
apy. Four studies reported the radiotherapy frac-
tionation schedules implemented during the CO-
VID-19 pandemic period (Tab. 2) [17, 21, 22, 24].
thematic analysis
Four themes emerged: preparing and equipping 
staff; reinforcing infection prevention and control 
policies; strengthening coordination and commu-
nication; and maintaining physical distancing. Dif-
ferent mitigation measures have also been sum-
marised in a matrix with 21 subthemes (Fig. 2).
Preparing and equipping staff
Within this theme, studies acknowledged the 
importance of preparing and equipping staff and 
supporting staff to manage emerging psycho-
social risks. Five studies reported providing staff 
with initial and ongoing education and training 
on correct use, maintenance and disposal of PPE, 
hand hygiene, disinfection procedures, isolation 
policies, symptoms of COVID-19 and latest na-
tional guidelines on diagnosing and managing CO-
VID-19 [13–15, 18, 21, 22]. Strategies frequently 
mentioned for delivering training included educa-
tional pamphlets and a blend of web-based learning 
and hands-on experience [14, 18, 21, 22]. In the 
early phase of the pandemic, lack of effective infec-
tion control programmes and weak enforcement 
mechanisms were major factors associated with in-
creased person-to-person transmission resulting in 
several radiation oncologists, two radiation thera-
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pists and an unknown number of patients having 
been infected with COVID-19 [15].
Eight studies reported that preparing and equip-
ping staff with programmes, policies and resourc-
es, such as non-contact temperature assessment 
devices, telehealth equipment, PPE, sterilisation 
technologies and disinfectants were crucial to sup-
port and protect staff to deliver safe radiotherapy 
[13–17, 19, 21, 22]. Lack of access to affordable 
PPE and stock shortages were obstacles to cancer 
Figure 1. PriSMa flow diagram
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database searching:





































ź Wrong population (n = 3)
ź Wrong setting (n = 13)
ź Lacks detailed strategy 
to mitigate COVID-19 (n = 8)
Full-text articles excluded, 
with reasons 
(n = 31
ź Editorials (n = 5)
ź Brief opinion (n = 1)
ź Letter (n =  1)
table 1. Summary of studies included in the review






to consider some 






adoption of a triage system
cOviD-19 testing
interruption of the treatment for at least two weeks for confirmed 
cOviD-19 cases




to outline guidelines 
that are both consensus-
based, representing major 
cancer treatment medical 
societies, and localised, 
taking into account local 





Discuss stereotactic ablative radiotherapy (SaBr) in patients with 
stage i and ii disease, especially if ≥ 70 years of age and at higher 
surgical risk
Prefer hypofractionated radiotherapy when possible
Use of PPe
adoption of a triage system
cOviD-19 testing
Use of telehealth for multidisciplinary team meetings
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table 1. Summary of studies included in the review
Authors Aim Design Country Measures
Gupta et al. 
2020
to clarify the common 
doubts being faced by 
the high-volume centres 
regarding the functioning 
of the department, the 
treatment of patients and 





clean waiting area with adequate distancing between the 
waiting benches and the patients
time slots defined for patients and treating no more than 5 
patients per hour
Stringent use mask and follow standard hand hygiene
education for staff on the correct use of PPe
thermal screening of all patients/staff at radiation premises
Staff divided into two groups
Use of telemedicine to minimise patients’ visits
the potential benefits and risks of altered fractionations 
discussed with patients
Minimal use of radiation accessories
withholding post-graduate teaching/online teaching platform
cOviD-19 testing for patients with travel history




to report the response 
of a comprehensive 
cancer centre in a lower-
middle income country 
to prevent cOviD-19 
transmission and how 
the implementation of 
pragmatic strategies have 
served as a springboard to 
improve cancer services 
beyond the cOviD-19 
pandemic.
case report Zambia
establishment of local taskforce
Staff training to ensure that all staff were adequately trained in 
the prevention of cOviD-19 transmission
Facilitation of good hygiene practices
adoption of a triage system
rethinking of patient scheduling





possible actions that 
should be considered by 
patients, their caregivers 
and families, physician, 
nurses, managers and 
staff of medical centres 





regular disinfection of the surfaces
Patients wearing of disposable gown
Patients wearing face masks when receiving their treatment
adopt a triage system
Use teleconferencing
Patients and their companions to wear while at the facility
weekly educational sessions to update staff
creating a call centre to answer the questions of patients and 
their families
limit the number of patient companions
Saab et al. 
2020
to investigate the impact 
of the pandemic and its 
associated response on 
the care of children with 









restrictions on visit to the facility
Social distancing in waiting rooms
closed the playroom/entertainment area
Phone/virtual clinic screening for all patients before 
appointments
Use of face mask by patient, family member, and staff
Full PPe for all health care professionals
regular surface disinfection
Proper hand hygiene
Opportunity for staff to work from home
Splitting of staff into two teams
Hypofractionation of radiotherapy when possible
Use of telehealth for follow-up, teaching activities and 
multidisciplinary team meetings
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care delivery [23]. The recommended solution in-
cluded improving communication lines for better 
centralised ordering and distribution of PPE [14]. 
Another study indicated that staff managing their 
mental health and psychosocial well-being during 
the COVID-19 crisis was essential due to increased 
table 1. Summary of studies included in the review
Authors Aim Design Country Measures
Samiee et 
al. 2020
to present our policy 
and recommendations 
at a private radiology-
oncology centre
case report iran
Developed cOviD-19 policies and guidelines
Use of face mask by patient, family member, and radiotherapy 
staff
avoid, defer or shorten radiotherapy when possible
Use of telehealth for follow-up visits
cancelled weekly visits for patients under treatment
create a direct hotline and whatsapp discussion platform
adoption of a triage system
Use of PPe
Opportunity to work from home
Practice physical distancing of at least 1.5 m
Stopped the use of physical wedges
Dedicated clinic for further cOviD-19 assessment and quarantine
wang et al. 
2020
to present the measures 
preventing and 
controlling cOviD-19 
taken at our hospital over 
the past 2 months, as well 
as their corresponding 
effects.
case report china
Developed cOviD-19 policies and guidelines
training for all radiotherapy staff
Partitioned the radiotherapy centre into zones
regular disinfection of the environment and equipment
Good air ventilation
Use of telehealth
adoption of a triage system
restriction on the number of escorts
a cloth or disposable sheet for each patient
Use of PPe
cOviD-19 testing
Dedicated hospital for further cOviD-19 assessment and 
quarantine
Proper waste management
wei et al. 
2020
to detail our infection 
control experience at the 
radiotherapy centre of the 
Hubei cancer Hospital
case report china
Formation of an ad hoc emergency infection control team
Partitioned the clinical area of the radiotherapy centre into three 
zones
training for radiotherapy staff
Staff rotation with no overlap
adoption of a triage system
wearing of face mask for all patients and accompanying carers
cOviD-19 testing
Dedicated isolation room for suspected cases
Dedicated hospital for further cOviD-19 assessment and 
quarantine
Hand hygiene
Use of telehealth for appointment, follow-up and consultations
a strict single-patient rule
Spacing of two meters or more at the waiting area
Use of PPe
effective disinfection of the environment and equipment
Good air ventilation
Strict adherence of medical waste management regulations
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table 1. Summary of studies included in the review
Authors Aim Design Country Measures
wu et al. 
2020
to briefly review the 
radiation therapy 
management in wuhan 
since January 2020, 
with the hope that the 
experience learned, and 
the lessons learned will 
help guide practice in 
other regions that are or 





adoption of a triage system
Health education fo patients
Developed cOviD-19 policies and guidelines 
Staff training
Divided the radiotherapy centre into zones
Single-use clear wrap for immobilisation devices
Use of PPe
Xie et al. 
2020
to report our experience 
and preliminary outcomes 
of 209 rt patients, who 
were treated at the 
Zhongnan Hospital of 
wuhan University (ZHwU) 
during the period when 
the city was locked down 
on Jan 23, 2020
case report china
adoption of a triage system
cOviD-19 testing
isolation space for suspected cases
Dedicated hospital for further cOviD-19 assessment and 
quarantine
wearing of face mask for all patients and carers
Strict distancing of at least 1.5 m apart
Daily disinfection
a buddy system to expedite the notification of unwell team 
members
Use of PPe
Splitting of staff into teams
Strict hand hygiene
effective disposal of medical hazard waste
Prohibition of team gatherings
table 2. radiotherapy fractionation schedules adopted by lMics during the cOviD-19 pandemic
Authors Country Site Fractionation schedules
aghili, Jafari & vand 
rajabpoor 2020
iran Head and neck
Oral tongue pt1–t2, N0: 39 Gy/13 fxa in 7 days, two times daily instead of 60 
Gy/30 fx by external radiotherapy
Prostate
Monotherapy in low-risk patients: recommend delaying the treatment for 
3–5 months
High risk: two fractions of 13.5 Gy a or 15 GY for booster dosages after 
external radiotherapy in one session
Baldotto et al. 2020 Brazil lung
initial disease: 45–54 Gy/3 fx
locally advanced disease: 60 Gy/30 fx or 55–60 Gy/20 fractions or 60 Gy/15 fx 
(recommended)
Gupta et al. 2020 india Head and Neck Postoperative: 55 Gy/25 fx
cervix
45 Gy/20 fx
two sessions of 9 Gy each delivered one week apart*
Brain High grade: 40 Gy/15 fx
rectum
Preoperative, short course: 25 Gy/5 fx (recommended)
Postoperative: 45 Gy/ 20 fx
Breast
whole breast only: 26 Gy/5 fx
chest wall only: 26 Gy/5 fx
Nodal irradiation needed: 40 Gy/15 fx
Palliative
Painful bone metastasis: 8 Gy/1 fx
Spinal cord compression < 48 hr: 8 Gy/1 fx
Symptomatic brain metastasis: 8 Gy/1 fx
tumour bleed: 8 Gy/1 fx
Superior ve na cava obstruction (symptomatic patients only): 20 Gy/5 fx
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stress [23]. However, the findings also showed that 
helpful coping strategies are significantly needed 
for staff, cancer patients and their families.
reinforcing infection prevention 
and control policies
All studies reported radiotherapy management 
commitment to reinforcing infection prevention 
and control policies to reduce the risk of transmis-
sion of COVID-19 at radiotherapy centres [13–23]. 
In most of these studies, staff wearing proper PPE 
(e.g. gowns, masks, face shields and gloves) [13–16, 
18, 21, 22], keeping treatment and other rooms 
well-ventilated [13, 14, 16], disinfecting surfaces 
that patients and staff are in constant contact with, 
such as treatment couch [13–16, 18, 19] adhering to 
strict hand hygiene [13, 14, 16, 18, 21, 22] and man-
aging waste effectively [13, 14, 16] were approaches 
frequently reported for creating safe infection con-
trol practice. Four studies reported cancer patients 
and their accompanying carers were required to 
wear face masks when entering the radiotherapy 
facility to protect themselves in a preventive man-
ner [14, 18, 19, 22]. Shortages of face masks in the 
community was a critical barrier. As a result, one 
study recommended providing cancer patients with 
sanitary packages containing face masks, gloves and 
hand sanitisers on arrival [18].
All studies highlighted the importance of adopt-
ing triage systems to sort, assess and prioritise staff, 
cancer patients and their carers entering the radio-
therapy centre [13–23]. From these studies design-
ing a flow chart helped facilitate the COVID-19 
table 2. radiotherapy fractionation schedules adopted by lMics during the cOviD-19 pandemic
Authors Country Site Fractionation schedules
lombe et al 2020 Zambia Breast
chest wall: 50 Gy/25 fx or 28.5 Gy/5 fx (recommended)
Supraclavicular + chest wall: 50 Gy/25 fx or 40 Gy/10 fx (recommended)
cervix
50 Gy/25 fx or 41.25 Gy/15 fx (recommended)
7 Gy/4 fx or 8 Gy x 3; 9 Gy x 2 one week apart; 9.4 Gy x 2 one week apart 
(recommended)*
Prostate High risk: 74 Gy/37 fx or 60 Gy/20 fx (recommended)
Palliative
Spinal cord compression: 20 Gy/5 fx or 30 Gy/5 fx or 8 Gy/1 fx 
(recommended)
*Dose of brachytherapy; Fx — fraction; Gy — Gray
Figure 2. cOviD-19 mitigation measures adopted by radiotherapy centres in lMics
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screening and testing process [16, 19]. Daily body 
temperature check at the entrance and asking can-
cer patients and their carers series of questions were 
critical to identifying if they presented symptoms 
indicative of COVID-19. Moreover, further studies 
showed that most radiotherapy centres in LMICs 
had implemented suspect case testing for staff, can-
cer patients and carers who have had close contact 
with a COVID-19 case and/or have symptoms of 
COVID-19 [13, 14, 16–19, 22, 23]. Overall, a sus-
pect case testing included chest computed tomog-
raphy (CT) scan and polymerase chain reaction 
(PCR) test [16] . Often studies highlighted that if 
results were abnormal, suspected cases were im-
mediately transported to a designated infectious 
disease institution equipped to manage suspected 
or confirmed cases of COVID-19 in line with na-
tional guidelines [13, 16].
Four studies reported that some radiotherapy 
centres strategy to mitigate the spread of the CO-
VID-19 included dividing the facility into three 
zones: clean zone; semi-contaminated zone; and 
contaminated zone [13–15, 18]. Administrative of-
fices, medical physics and dosimetry offices were 
reported as clean zones while semi-contaminated 
zones included changing and restrooms, patient 
corridors and waiting areas. Contaminated zones 
comprised treatment vaults, simulation rooms, 
consulting rooms, console areas and front desk ar-
eas [14]. Posting reminder signs for staff to remove 
contaminated PPE before leaving designated con-




Studies recognised that strengthening good com-
munications among staff, and between staff and 
cancer patients can enhance coordination and mo-
bilise support around policy to provide safe radio-
therapy services, including brachytherapy for can-
cer patients with the maximum level of protection 
[17]. A belief commonly reported was the percep-
tion that eliminating COVID-19 soon was a false 
hope. Therefore, most radiotherapy centres have 
undertaken efforts that included forming COV-
ID-19 response multidisciplinary teams intended to 
improve internal coordination and communication 
by rapidly developing clinical guidelines (e.g. lung, 
breast, cervical and prostate cancers), policies and 
channel advice on health and safety during the CO-
VID-19 pandemic [14, 21]. Some studies revealed 
that the COVID-19 response multidisciplinary 
team was responsible for coordinating all aspects 
of infection control activities, which included staff 
training, radiotherapy workflow modification and 
management of PPE [14, 21].
Further initiatives to strengthening coordination 
and communication included establishing a hotline 
for cancer patients and their families as well as using 
social media (e.g. WhatsApp) for cancer patients to 
notify the designated staff member responsible for 
handling complaints [19]. Other studies reported 
discussing radiotherapy with new cancer patients 
via telehealth (either phone or video) and making 
decisions on avoiding, deferring or shortening treat-
ment [19]. All studies acknowledged that COVID-19 
is a challenging situation and information keeps 
changing as new guidelines are developed. Therefore, 
providing weekly information sessions for all staff 
to update and advice staff on the latest changes to 
cancer and COVID-19 guidelines was essential [18].
Maintaining physical distancing
All studies reported that radiotherapy centres 
had implemented multiple strategies to allow for 
physical distancing to reduce the likelihood of ex-
posure to micro-droplets infections [13, 14, 16, 18, 
19, 21–23]. Adjusting the layout of waiting areas, 
rethinking appointments to reduce the capacity of 
patient flow (e.g. two patients for every 30–40 min-
utes timeslot), allowing a single patient in a con-
sultation room at a time, designating separate en-
trance and exit and restricting the number of carers 
accompanying patients were among the most fre-
quently mentioned strategies to create space while 
maintaining a distance of at least one meter around 
individuals [13, 16, 18, 19, 21]. 
Four studies reported that splitting staff into two 
or three separate teams helped to reduce the num-
ber of staff on-site at any given time [13, 14, 16, 22]. 
Particularly, a single study indicated that schedules 
were modified to ensure there was no overlap of 
staff [14]. Similarly, some radiotherapy centres have 
developed a flexible arrangement that allows certain 
staff, such as medical physicists and dosimetrists to 
work from home. Staff with proper equipment and 
training were able to perform remote treatment 
planning [14]. In one study, simulation sessions 
were reduced to two days per week [19].
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Five studies reported that radiotherapy centres 
had arranged a dedicated space for isolation of any 
patient, carer and/or staff who develops COVID-19 
symptoms at the radiotherapy site [13, 14, 16, 18, 
19]. The availability of isolation room helped keep 
suspected cases separate while awaiting transfer 
to a dedicated COVID-19 facility. Some studies 
showed that staff and other patients who may have 
been in contact with confirmed COVID-19 case 
were asked to practice self-quarantine [13].
A large number of studies indicated increased 
use of telehealth instead of face-to-face consulta-
tions to mitigate the spread of the COVID-19 [13, 
18–23]. Telehealth provided a crucial advantage in 
the delivery of multidisciplinary team meetings, 
follow-ups with patients after treatment irrespec-
tive of location, triage for patient booking appoint-
ment and education [13, 18–23]. Inherently, issues 
relating to implementing and sustaining telehealth 
in radiotherapy, as well as infrastructure that facili-
tate equitable telehealth access during COVID-19 
were not examined in the included studies. Without 
sustainability planning and actions to address bar-
riers to accessing telehealth, radiotherapy leaders 
risk creating telehealth programmes that exclude 
specific individuals and populations, such as rural 
patients.
Discussion
This systematic review was conducted to synthe-
sise the current evidence on measures implemented 
by radiotherapy centres in LMICs to reduce the risk 
of contracting COVID-19. The literature indicates 
that radiotherapy centres in LMICs have imple-
mented multi-component strategies to: reinforce 
infection prevention and control policies; prepare 
and equip staff; strengthen coordination and com-
munication; and maintain physical distancing. The 
most commonly reported strategies included: us-
ing telehealth; wearing PPE; hand hygiene, split-
ting staff into separate teams; zoning; working from 
home; training staff; weekly information sessions; 
developing guidelines, procedures and protocols; 
adjusting the layout of waiting areas; designating 
separate entrance and exit; restricting the number 
of accompanying carers; adopting triage systems; 
COVID-19 testing; and arranging a dedicated space 
for isolation. However, it is difficult to determine 
the effectiveness of these strategies because includ-
ed studies have methodological limitations and 
provided minimal information about their impact.
Radiotherapy staff are committed to providing 
safe services to cancer patients and must be pro-
tected against COVID-19 at all times [8]. There 
is evidence showing that more than 3,300 health-
care workers in China have been infected as of 
March 2020 [25]. Recognising that transmission 
occurs via symptomatic and asymptomatic indi-
viduals, preparation and protection are especially 
important. Effective protection of radiotherapy 
staff is likely to be dependent on a combination of 
special training on infection control, availability 
and proper use of PPE, provision of safe air (good 
ventilation) and administrative controls, such as 
triage systems to identify, isolate, investigate and 
effectively manage individuals who may present 
COVID-19 symptoms. Developing and implement-
ing evidence-based COVID-19 control policies and 
procedures provide guidance for reducing the risk 
of transmission of COVID-19 in the radiotherapy 
setting [6]. To protect staff, cancer patients and 
their families, radiotherapy leaders have both ad-
ministrative and supervisory responsibilities to pe-
riodically evaluate and revise COVID-19 infection 
control policies and procedures. The review shows 
that a radiotherapy centre COVID-19 infection 
control policy ideally needs to update cleaning and 
disinfection procedures and outline arrangements 
for isolating and transferring suspected cases to 
a dedicated COVID-19 facility for further inves-
tigation and management, so patients with CO-
VID-19 do not infect others.
In many LMICs, cancer patients and their ac-
companying carers are required to wear facemasks 
when entering a radiotherapy centre to provide 
additional protection when needed. However, it 
presents additional communication challenges for 
both staff and cancer patients. Radiotherapy lead-
ers taking advantage of technology, such as speech 
applications on smartphones, can help address 
communication challenges. As COVID-19 spreads 
globally, demand for PPE has increased creating 
shortage problems. It is estimated that the need for 
surgical masks, gloves and face shields could reach 
2.2 billion, 1.1 billion and 8.8 million, respective-
ly, through the end of 2020 (UNICEF 2020 [26]). 
Other studies have shown that adequate produc-
tion and distribution of PPE are crucial to caring 
for patients during COVID-19 pandemic [27, 28]. 
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Our review supports those findings. For example, 
to optimise the supply of PPE, radiotherapy cen-
tres in LMICs could implement strategies such as: 
creating partnerships with not-for-profit organisa-
tions and/or national coalition of centres in cancer 
care; training staff on PPE donning and doffing 
procedures; storing PPE in secured and monitored 
locations; providing facemasks to patients at the 
entrance; ensuring extended use of facemasks; and 
limiting face-to-face contact by maximising the use 
of telehealth.
Findings from the review suggest that the emer-
gence of COVID-19 has caused a rapid adoption 
of telehealth in radiotherapy services, with no in-
formation on sustainability. This finding is con-
sistent with previous studies, which recommend 
careful planning, implementation and evaluation to 
ensure equity and sustainability of telehealth after 
the COVID-19 crisis [29, 30]. Telehealth in radio-
therapy services helps maintain physical distancing. 
New cancer patient consultations, multidisciplinary 
team meetings and follow-up are made possible 
through telehealth. If telehealth is to have signif-
icant impact in radiotherapy services in LMICs, 
leaders need to: develop education and training 
for cancer patients to acquire the requisite digital 
skills; advocate for free or less expensive internet 
service charges; secure funding to expand and sus-
tain telehealth; and identify cancer patients who are 
unable to engage in video follow-up due to the lack 
of device [31].
It is worth noting that COVID-19 practical ra-
diotherapy treatment recommendations for can-
cers, such as breast, cervix, lung, head and neck, 
prostate and colorectal, have been published by var-
ious international and national organisations and 
societies [32–34]. For palliative non small cell lung 
carcinoma, 8-10 Gy/1 fraction is strongly recom-
mended [35]. Consensus-based recommendations 
from American Society for Radiation Oncology 
and European Society for Radiology and Oncol-
ogy strongly suggest 50 Gy/16 fractions for early 
larynx cancer (T1N0) [34]. However, more robust 
evidence is required to support some of the frac-
tionations for head and neck tumors [35].
Strengths and limitations
This is the first systematic review to synthesise 
the evidence on COVID-19 mitigation measures 
implemented by radiotherapy centres in LMICs. 
Multiple electronic databases were searched to mi-
nimise the risk of missing studies. However, it is 
possible that other studies were not identified be-
cause of the rapidly changing field and publication 
rate. Majority of the studies were from China and it 
may not be possible to generalise the results. None 
of the studies described an intervention that uses 
incentive to both encourage self-isolation and pre-
pare staff to face a health crisis, such as COVID-19.
conclusion
As radiotherapy centres in LMICs navigate 
through and beyond COVID-19, it is important 
to seize the opportunity to recognise and address 
challenges to strengthen radiotherapy workforce. 
Engaging and equipping staff, cancer patients and 
their families with the necessary resources, infor-
mation, knowledge and skills are critical success 
factors to ensure adherence to measures, such as 
physical distancing and quarantine. A coordinated 
approach to communicating messages to staff, can-
cer patients and their families is equally important 
to prevent confusion, mistrust and uncertainty. 
Subsequent studies are needed to explore and ex-
plain the effectiveness of the strategies identified 
in the review. The real strength of radiotherapy 
leaders to reduce the risk of COVID-19 in radio-
therapy centres in LMICs comes from their abil-
ity to be flexible and innovative. New models for 
radiotherapy services may emerge from the CO-
VID-19 pandemic. Robust and high quality data 
collection must be encouraged in LMICs to provide 
an evidence-based knowledge for use in the event 
of another pandemic.
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